[
  {
    "ts": null,
    "headline": "Looking at the Narrative for GE HealthCare as Margin Execution and Tech Upside Reshape Expectations",
    "summary": "GE HealthCare Technologies stock has seen only a marginal uptick in its fair value estimate to about $89.22 per share, even as the assumed discount rate has eased from roughly 8.40% to around 8.30%. This shift reflects growing confidence in mid term execution rather than a wholesale re rating. At the same time, slightly softer long term revenue growth assumptions near 4.26% suggest analysts are balancing that optimism with caution around macro and market specific risks. As these small but...",
    "url": "https://finnhub.io/api/news?id=00e2c41c8eceab50512dae49117250bf3b34abc41222c345102ed48928bb6381",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766023995,
      "headline": "Looking at the Narrative for GE HealthCare as Margin Execution and Tech Upside Reshape Expectations",
      "id": 137817061,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "GE HealthCare Technologies stock has seen only a marginal uptick in its fair value estimate to about $89.22 per share, even as the assumed discount rate has eased from roughly 8.40% to around 8.30%. This shift reflects growing confidence in mid term execution rather than a wholesale re rating. At the same time, slightly softer long term revenue growth assumptions near 4.26% suggest analysts are balancing that optimism with caution around macro and market specific risks. As these small but...",
      "url": "https://finnhub.io/api/news?id=00e2c41c8eceab50512dae49117250bf3b34abc41222c345102ed48928bb6381"
    }
  },
  {
    "ts": null,
    "headline": "How Indonesia’s SIHREN CT Deal And New Financing At GEHC Have Changed Its Investment Story",
    "summary": "In mid-December 2025, Vaso Corporation’s VasoHealthcare unit extended its U.S. sales representation agreement for GE HealthCare’s diagnostic imaging and ultrasound portfolio through 2030, while GE HealthCare also arranged new debt financing to help fund its planned acquisition of Intelerad Medical Systems. GE HealthCare additionally secured a multi-year, competitively tendered contract to supply more than 300 CT scanners under Indonesia’s SIHREN program, underscoring its role in large-scale...",
    "url": "https://finnhub.io/api/news?id=36b64e0aea2c20b69fda26bbed1be8bf1dc508f543ad4650d598831605a50910",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766016897,
      "headline": "How Indonesia’s SIHREN CT Deal And New Financing At GEHC Have Changed Its Investment Story",
      "id": 137817742,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GEHC",
      "source": "Yahoo",
      "summary": "In mid-December 2025, Vaso Corporation’s VasoHealthcare unit extended its U.S. sales representation agreement for GE HealthCare’s diagnostic imaging and ultrasound portfolio through 2030, while GE HealthCare also arranged new debt financing to help fund its planned acquisition of Intelerad Medical Systems. GE HealthCare additionally secured a multi-year, competitively tendered contract to supply more than 300 CT scanners under Indonesia’s SIHREN program, underscoring its role in large-scale...",
      "url": "https://finnhub.io/api/news?id=36b64e0aea2c20b69fda26bbed1be8bf1dc508f543ad4650d598831605a50910"
    }
  }
]